| Financial Year |
March 31 2023 |
| Monetary Funds |
1,827,630,465.61 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,723,772,481.08 |
| Accounts Receivable |
3,893,023,750.56 |
| Advances to Suppliers |
125,839,110.57 |
| Other Receivables |
58,556,216.77 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,298,854,772.52 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,062,395.50 |
| Total Current Assets |
11,041,515,323.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
319,363,529.75 |
| Investment Properties |
606,594,306.66 |
| Fixed Assetes |
1,640,166,363.06 |
| Under-construction Projects |
328,000,905.67 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
153,962,277.63 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
91,435,625.66 |
| Deferred Income Tax Assets |
112,753,658.19 |
| Other Non-Current Assets |
77,645,160.82 |
| Sub-Total of Non-Current Assets |
3,578,912,235.20 |
| Total Assets |
14,620,427,558.82 |
| Short-Term Loans |
365,551,746.36 |
| Trading Financial liabilities |
-- |
| Notes Payable |
359,742,506.13 |
| Accounts Payable |
1,302,114,940.05 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
91,794,441.75 |
| Taxes Payable |
292,323,110.80 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
68,252,453.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
75,678,680.06 |
| Other Current Liabilities |
4,943,681.58 |
| Sub-Total of Current Liabilities |
2,636,784,186.05 |
| Long-term Loans |
803,061,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
89,954,542.52 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
104,576,091.56 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,493,812,256.17 |
| Total Liabilities |
4,130,596,442.22 |
| Paid-In Capital(Or Share Stock) |
520,413,168.00 |
| Capital Surplus |
3,048,165,207.94 |
| Surplus Reserve |
435,478,457.41 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
6,423,546,191.27 |
| Minority Stockholder's Interest |
-3,123,392.90 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,492,954,509.50 |
| Owner's Equity（Stockholder's Equity） |
10,489,831,116.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,620,427,558.82 |
